SweetValueLab
Write for us

Solventum Corporation — Intrinsic Value & Fair Price

SOLV
NYSEHealthcareMedical - Instruments & SuppliesCIK 0001964738solventum.comAbout SOLV
Valuation grade ?S
Quant grade ?B
Last close · Oct 30, 202681.33−2.23 (−2.67%)
Model value · DCF · Perpetuity growth · 5y
134.30
Solventum closed at $81.33 — undervalued by 39% vs model.
104.54the model's range180.20

DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
57.24 – 199.91
Wall St. target
100.50 19% below
Below model, 1y
30 of 30 days

How it is valued

Valued asMature & stable
Low/slowing growth (~1% recent)Moderate margins (19% net margin)Highly cyclical earningsNegative free cash flow
What growth the price implies: the reverse DCF

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.